Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghiorzo

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Melanoma Research|November 18, 2008
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutationsMarina Vignoli, Maria Chiara Scaini, Paola Ghiorzo, et al.
Melanoma Research|April 3, 2009
CDKN2A and MC1R analysis in amelanotic and pigmented melanomaPaola Ghiorzo, Lorenza Pastorino, Maria A Pizzichetta, et al.
Journal of Medical Genetics|October 7, 2018
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline <i>CDKN2A</i> mutationsHildur Helgadottir, Paola Ghiorzo, Remco van Doorn, et al.
Diagnostic Pathology|December 15, 2020
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)Irene Vanni, Milena Casula, Lorenza Pastorino, et al.
Plos Genetics|November 16, 2019
Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing StudiesAndrew Schlafly, Ruth M Pfeiffer, Eduardo Nagore, et al.
Human Mutation|March 25, 2014
CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessmentMaria Chiara Scaini, Giovanni Minervini, Lisa Elefanti, et al.
Melanoma Research|December 4, 2004
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patientsMichela Mantelli, Lorenza Pastorino, Paola Ghiorzo, et al.
Human Molecular Genetics|August 9, 2006
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastomaPaola Ghiorzo, Sara Gargiulo, Lorenza Pastorino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in ItalyPaola Ghiorzo, Sara Gargiulo, Sabina Nasti, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 8, 2013
Molecular characterization of an Italian series of sporadic GISTsP Origone, S Gargiulo, L Mastracci, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Melanoma Research|November 18, 2008
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutationsMarina Vignoli, Maria Chiara Scaini, Paola Ghiorzo, et al.
Melanoma Research|April 3, 2009
CDKN2A and MC1R analysis in amelanotic and pigmented melanomaPaola Ghiorzo, Lorenza Pastorino, Maria A Pizzichetta, et al.
Journal of Medical Genetics|October 7, 2018
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline <i>CDKN2A</i> mutationsHildur Helgadottir, Paola Ghiorzo, Remco van Doorn, et al.
Diagnostic Pathology|December 15, 2020
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)Irene Vanni, Milena Casula, Lorenza Pastorino, et al.
Plos Genetics|November 16, 2019
Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing StudiesAndrew Schlafly, Ruth M Pfeiffer, Eduardo Nagore, et al.
Human Mutation|March 25, 2014
CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessmentMaria Chiara Scaini, Giovanni Minervini, Lisa Elefanti, et al.
Melanoma Research|December 4, 2004
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patientsMichela Mantelli, Lorenza Pastorino, Paola Ghiorzo, et al.
Human Molecular Genetics|August 9, 2006
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastomaPaola Ghiorzo, Sara Gargiulo, Lorenza Pastorino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in ItalyPaola Ghiorzo, Sara Gargiulo, Sabina Nasti, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 8, 2013
Molecular characterization of an Italian series of sporadic GISTsP Origone, S Gargiulo, L Mastracci, et al.
Pageof 15